Healthcare
Customer Exposure
Nearly all revenues come from life sciences customers, so industry-wide regulatory or funding changes directly affect Veeva's demand and revenue.
Relevance 98·Dependency 95·Confidence 97
Source evidence
“Nearly all of our revenues are generated by sales to customers in the life sciences industry, and factors that adversely affect this industry”
Subscription revenues (84% of total)
Revenue Exposure
Subscription fees dominate the revenue model (84% of FY2026 total revenues), recognized ratably over noncancellable terms.
Relevance 95·Dependency 85·Confidence 97
Source evidence
“Subscription revenues are generally recognized ratably over the respective noncancellable subscription term”
Veeva Vault platform
Revenue Exposure
Veeva Vault is the proprietary platform underpinning Development Cloud, Quality Cloud, Vault CRM, and Veeva AI agents; its adoption and security are central to revenue.
Relevance 90·Dependency 85·Confidence 93
Source evidence
“Veeva AI adds agentic artificial intelligence (“AI”) to our proprietary Veeva Vault platform and deep, industry-specific agents for Veeva applications.”
Amazon Web Services
Supplier Dependency
Cost of subscription revenues includes third-party computing infrastructure from AWS (and Salesforce), a key operational dependency for hosting subscription services.
Relevance 85·Dependency 80·Confidence 95
Source evidence
“expenses related to our computing infrastructure provided by third parties, including Amazon Web Services and Salesforce, Inc.”
Salesforce, Inc.
Technology Dependency
Legacy Veeva CRM and related applications are built on Salesforce's platform, supported only until December 31, 2029, while Salesforce is also Veeva's primary CRM competitor.
Relevance 85·Dependency 55·Confidence 95
Source evidence
“Veeva CRM and some of its related applications are built on a platform provided by Salesforce, Inc. and will be supported until December 31, 2029.”
R&D and Quality Solutions
Demand Driver
Management expects R&D and Quality Solutions revenues to increase as a share of subscription and total revenues, driving future revenue mix.
Relevance 85·Dependency 55·Confidence 95
Source evidence
“Revenues associated with our R&D and Quality Solutions are expected to increase as a percentage of both subscription revenues and total revenues in the future.”
Government regulation / life sciences compliance
Revenue Exposure
Solutions help life sciences companies maintain compliance with government regulations, tying demand to regulatory requirements.
Relevance 80·Dependency 50·Confidence 90
Source evidence
“market and sell more effectively, and maintain compliance with government regulations.”
Salesforce, Inc.
Customer Exposure
Customers may migrate to Salesforce CRM during the Vault CRM transition; large customers have already committed to Salesforce.
Relevance 80·Dependency 45·Confidence 93
Source evidence
“Salesforce, our primary CRM competitor, has announced that certain large Veeva CRM customers have committed to purchasing its CRM solutions”
Salesforce, Inc.
Supplier Dependency
Salesforce, Inc. is a named third-party infrastructure provider for subscription services.
Relevance 75·Dependency 70·Confidence 93
Source evidence
“including Amazon Web Services and Salesforce, Inc.”
Third-party computing infrastructure providers
Supplier Dependency
Veeva relies on third-party providers for computing infrastructure and network connectivity to deliver its cloud solutions; disruption would harm the business.
Relevance 75·Dependency 70·Confidence 90
Source evidence
“We rely on third-party providers for computing infrastructure, secure network connectivity, and other technology-related services needed to deliver our cloud solutions”
Third-party cloud hosting infrastructure
Cost Driver
Cost of subscription revenues includes third-party hosting infrastructure and data acquisition costs.
Relevance 75·Dependency 65·Confidence 92
Source evidence
“expenses related to our computing infrastructure provided by third parties”
Inflation Reduction Act
Regulatory Exposure
U.S. drug pricing reforms under the IRA could lower life sciences customer revenues and profits, reducing demand for Veeva products.
Relevance 75·Dependency 55·Confidence 90
Source evidence
“Significant changes in drug pricing policy or regulation could result in lower revenues and profits for life sciences companies and reduced demand for our products.”
Life sciences sales representatives
Demand Driver
Reduction in pharma sales reps due to digital channel preference has negatively impacted demand for Veeva CRM and other Commercial Solutions.
Relevance 70·Dependency 60·Confidence 90
Source evidence
“which negatively impacted sales of our solutions, including Veeva CRM and certain of our other Commercial Solutions”
Data privacy and life sciences regulation
Legal Exposure
Complex U.S. and international data privacy and life sciences-specific regulations may impose compliance costs, reduce demand, and create liability.
Relevance 70·Dependency 50·Confidence 90
Source evidence
“Changing laws, regulations, and enforcement priorities, including increasingly complex U.S. and international data privacy and information security regulations and measures specific to the life sciences industry, may impose additional costs for compliance, reduce demand”
IQVIA
Competitive Exposure
IQVIA competes across CRM (via licensing to Salesforce), Data Cloud/Crossix analytics, and certain Development/Quality Cloud applications.
Relevance 70·Dependency 40·Confidence 92
Source evidence
“Our Veeva Data Cloud products as well as Veeva Crossix, compete with IQVIA, Ipsos Group S.A., Definitive Health Corp.”
EU/UK GDPR
Regulatory Exposure
Veeva is regulated under EU and UK GDPR as data controller for data products and processor for software products; non-compliance may impose significant liabilities and reduce demand.
Relevance 65·Dependency 50·Confidence 90
Source evidence
“we are regulated under the European General Data Protection Regulation (“EU GDPR”) and the United Kingdom’s General Data Protection Regulation (“UK GDPR”)”
Geopolitical conflicts and trade policy
Geopolitical Exposure
Tariffs, inflation, currency fluctuations, interest rates, Russia-Ukraine and Middle East conflicts, and recession concerns could negatively impact business and results.
Relevance 60·Dependency 40·Confidence 90
Source evidence
“geopolitical conflicts (like the Russian invasion of Ukraine and the conflict in the Middle East), and concerns about a possible domestic or global recession”
Geopolitical risk
Geopolitical Exposure
Wars, sanctions, export controls, and tariffs can delay or reduce customer IT spending in affected regions.
Relevance 60·Dependency 40·Confidence 85
Source evidence
“our customers may delay or reduce their IT spending, particularly within the regions impacted by negative economic or geopolitical conditions”
Third-party subcontractors (professional services)
Cost Driver
Professional services cost intensity driven by direct labor and subcontractor costs.
Relevance 60·Dependency 40·Confidence 90
Source evidence
“due to the direct labor costs and costs of third-party subcontractors”
Results are subject to FX fluctuations, particularly against the Euro among other currencies; Veeva hedges foreign currency transactions.
Relevance 50·Dependency 35·Confidence 90
Source evidence
“particularly changes in the Euro, Japanese Yen, Canadian Dollar, Great British Pound Sterling, and Chinese Yuan”
Veeva is in certain cases regulated under HIPAA covering protected health information held by covered entities and their business associates.
Relevance 50·Dependency 35·Confidence 85
Source evidence
“we are regulated under the U.S. Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) that covers protected health information”
International tax reform (Pillar Two, OBBBA)
Tax Exposure
OECD Pillar Two evolution and the One Big Beautiful Bill Act's TCJA extensions and R&D expensing restoration impact Veeva's tax payments and financial results.
Relevance 50·Dependency 35·Confidence 85
Source evidence
“the One Big Beautiful Bill Act includes significant tax provisions such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act of 2017”